Literature DB >> 20221614

Successful treatment of cardiac manifestation of eosinophilic leukemia.

Alexander Hess, Grigorios Korosoglou, Wolfgang Rottbauer, Hugo A Katus, Derliz Mereles.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20221614     DOI： 10.1007/s00392-010-0143-9

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  10 in total

1.  Clinical and echocardiographic features of hypereosinophilic syndromes.

Authors:  S R Ommen; J B Seward; A J Tajik
Journal:  Am J Cardiol       Date:  2000-07-01       Impact factor: 2.778

2.  Eosinophilic pericarditis: a rare complication of idiopathic hypereosinophilic syndrome in a child.

Authors:  R Spiegel; D Miron; D Fink; H Gavriel; Y Horovitz
Journal:  Pediatr Cardiol       Date:  2004 Nov-Dec       Impact factor: 1.655

3.  Reversal of cardiac abnormalities in a young man with idiopathic hypereosinophilic syndrome using a tyrosine kinase inhibitor.

Authors:  Luigi Ascione; Mario De Michele; Maria Accadia; Pasquale Spadaro; Salvatore Rumolo; Bernardino Tuccillo
Journal:  Eur J Echocardiogr       Date:  2004-10

4.  Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report.

Authors:  Amy D Klion; Bruce S Bochner; Gerald J Gleich; Thomas B Nutman; Marc E Rothenberg; Hans-Uwe Simon; Michael E Wechsler; Peter F Weller
Journal:  J Allergy Clin Immunol       Date:  2006-05-03       Impact factor: 10.793

Review 5.  Hypereosinophilic syndrome: an update.

Authors:  H Jeffrey Wilkins; Martin M Crane; Kelly Copeland; William V Williams
Journal:  Am J Hematol       Date:  2005-10       Impact factor: 10.047

Review 6.  The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.

Authors:  M J Chusid; D C Dale; B C West; S M Wolff
Journal:  Medicine (Baltimore)       Date:  1975-01       Impact factor: 1.889

7.  The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature.

Authors:  J E Parrillo; J S Borer; W L Henry; S M Wolff; A S Fauci
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

8.  Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias.

Authors:  P Vandenberghe; I Wlodarska; L Michaux; P Zachée; M Boogaerts; D Vanstraelen; M-C Herregods; A Van Hoof; D Selleslag; F Roufosse; M Maerevoet; G Verhoef; J Cools; D G Gilliland; A Hagemeijer; P Marynen
Journal:  Leukemia       Date:  2004-04       Impact factor: 11.528

9.  Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome.

Authors:  Amy D Klion; Jamie Robyn; Cem Akin; Pierre Noel; Margaret Brown; Melissa Law; Dean D Metcalfe; Cynthia Dunbar; Thomas B Nutman
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

Review 10.  Hypereosinophilic syndromes.

Authors:  Florence E Roufosse; Michel Goldman; Elie Cogan
Journal:  Orphanet J Rare Dis       Date:  2007-09-11       Impact factor: 4.123
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.